Hamilton Robotics has announced a collaboration with Promega to automate the Celltiter-Glo luminescent cell viability assay on Hamilton's Microlab Star liquid handling workstation.
The two companies have developed an automated, tested and verified protocol for the fast and accurate dispensing of the Promega reagent in microplate format.
Cell viability assays are widely used in biotech, pharmaceutical and academic research, providing information on cell health, proliferation and toxicity.
In addition to drug discovery, common applications include research on disease, environmental damage and implant rejection.
The Hamilton Star eight-channel platform, with its air displacement pipetting technology, performs precise dispensing of the Celltiter-Glo reagent in 96- or 384-well plate formats and can process multiple plates per day for high-throughput labs.
An integrated shaker effectively disrupts cells at 400rpm in 96-well plate format.
